Mind + Muscle

technical minds + legal muscle


dig deep

PTAB Decision Not To Sanction Bass Shifts Focus To Capitol

  • 09.29.15
  • Eldora Ellison, Ph.D.
  • Law360

Eldora Ellison, Ph.D., is quoted in Law360's "PTAB Decision Not To Sanction Bass Shifts Focus To Capitol," discussing the Patent Trial and Appeal Board's (PTAB) decision not to penalize hedge fund manager Kyle Bass for challenging drug patents in American Invents Act reviews.

Since the PTAB's decision, new issues have come to the forefront as hedge funds can legally file a petition to challenge a patent.

"At the end of the day, the real issue should be the merits of the patent being challenged," said Ellison. "If it's a weak patent, maybe anyone really should be able to challenge it."

She continued, "These cases will continue to be closely watched. I'm sure the board is aware of that, and they'll do their best to analyze the patents on the merits."

For more information regarding the PTAB decision, visit Law360.com.

Related People

Sort By Media Type

Sort By Media Type
  • AlertAlert
  • BriefsBriefs
  • Comments to USPTOComments to USPTO
  • Design Patent Case DigestDesign Patent Case Digest
  • MultimediaMultimedia
  • News & ArticlesNews & Articles
  • Press ReleasePress Release
  • VideoVideo
  • WebinarWebinar

Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.